DOCSLIB.ORG

Surgery Website

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Surgery Website Los Angeles Medical Center Surgery Residency Program Resident Scholarly Activities 2019 – 2020 Publication: D’Andrea, AP, McLemore, EC, Bonaccorso, A, Cuevas, J, Basam, M, Tsay A, Bhasin, D, Attaluri V, Sylla, P. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve. Surg Endosc 34, 4101–4109 (2020). https://doi.org/10.1007/s00464-019-07172-4 Fergus J, Nelson DW, Sung M, Lee D, Lavotshkin S, Difronzo LA, O’Connor VV. Pancreatectomy in Stage I pancreas cancer: national underutilization of surgery persists [published online ahead of print, 2020 Apr 22]. HPB (Oxford). 2020;S1365-182X(20)30101-5. doi:10.1016/j.hpb.2020.03.017 Young S, Sueda SK, Hotta M, Sung ML, OʼConnor VV, Leung AM. Surgical management of appendiceal mucinous neoplasm: Is appendectomy sufficient? [published online ahead of print, 2020 Jul 7]. J Surg Oncol. 2020;10.1002/jso.26108. doi:10.1002/jso.26108 Young S, DiFronzo LA, Ahuja A, et al. Performing Omentectomy During Gastrectomy Does Not Improve Survival: a Multi-Center Analysis of 471 Patients with Gastric Adenocarcinoma [published online ahead of print, 2020 Aug 12]. J Gastrointest Surg. 2020;10.1007/s11605-020- 04772-7. doi:10.1007/s11605-020-04772-7 Young S, Lo H, O’Connor V, DiFronzo L. Is outpatient laparoscopic liver resection possible? Factors predicting safe ultra-short hospital stay after laparoscopic hepatectomy. HPB 2020; 22(S1): S156-157. Angotti LM, Casey C, Ata A, Stefanie S, Ettekal Y, Lee C, Bonville D, Stain S, Tafen M . New Protocol Avoiding Tube Feed Interruptions in Critically Ill Patients Requiring Tracheostomy. Am Surg. 2018;84(6):983-986. Sung ML, Young S, Nelson DW, DiFronzo LA, O’Connor VV. A multicenter 10-year experience with hepatocellular adenoma: Is it time to redefine management paradigm? HPB 2019; 21(S1): S59. Hotta M, Khurana M, Sung M, O'Connor VV. Understanding the Biology of Occult Breast Cancer: Examination of 31 Cases Reveals Aggressive Behavior. Am Surg. 2020;86(3):e116-e118. Kang E, Collins JC. Primary Umbilical Hernia Repair: A Large-Volume Single-Surgeon Study. Am Surg. 2019;85(10):1159-1161. Page 1 of 5 Yong H, Chen Q, Yoo EY, Lau S, Vazquez W, Shaul S, Sydorak R. How Does Resident Participation Alter the Outcome of Surgery for Pectus Excavatum?. J Surg Educ. 2020;77(1):150-157. doi:10.1016/j.jsurg.2019.07.020 Cheng M, Chen Q, Tran-McCaslin M, Chun L, Lew W, Patel K. Endovascular Abdominal Aortic Aneurysm Repair: Does Anesthesia Type Matter?. Ann Vasc Surg. 2019;61:284-290. doi:10.1016/j.avsg.2019.04.031 Cheng M, Lavi P, Tran-McCaslin M, Chun L, Lew W, Patel K. Aortoiliac Endarterectomy: A Useful Tool in Modern Vascular Practice [published online ahead of print, 2020 May 20]. Ann Vasc Surg. 2020;S0890-5096(20)30421-0. doi:10.1016/j.avsg.2020.04.077 Ungerleider G, Cheng M, Park C, Matsushima K. Ileal Endometriosis: a Rare Cause of Enterocutaneous Fistula. J Gastrointest Surg. 2019;23(7):1524-1526. doi:10.1007/s11605-018- 3976-6 Ashfaq A, Esmaili S, Najjar M, et al. Utilization of Mobile Mental Health Services among Syrian Refugees and Other Vulnerable Arab Populations-A Systematic Review. Int J Environ Res Public Health. 2020;17(4):1295. Published 2020 Feb 18. doi:10.3390/ijerph17041295 Huang SY, Zhang M, David M, Radiology’s Engagement with Transgender Breast Imaging: Review of Radiology Practice Websites and Publications, Journal of Breast Imaging, Volume 2, Issue 2, March/April 2020, Pages 147–151, https://doi.org/10.1093/jbi/wbz081 Page 2 of 5 Presentation: Young S, Lo HYA, Difronzo LA. Is Outpatient Laparoscopic Liver Resection Possible? Factors Predicting Safe Ultra-Short Hospital Stay After Laparoscopic Hepatectomy. Poster Presentation at the Americas Hepato-Pancreato-Biliary Association Annual Meeting. Miami Beach, FL, March 6, 2020. Young S. Surgical Management of Appendiceal Mucinous Neoplasms: Is Appendectomy Sufficient? Podium Presentation at the Pacific Coast Surgical Association Annual Meeting. Carlsbad, CA, February 15, 2020. Young S, Difronzo LA. Performing Omentectomy During Gastrectomy Does Not Improve Survival: A Multi-Center Analysis of 471 Patients with Gastric Adenocarcinoma. Mini-Podium Presentation at the Pacific Coast Surgical Association Annual Meeting. Carlsbad, CA, February 15, 2020. Sueda S, Young S, Sung M, Hotta M, O’Connor V, Leung A. “Predictors of Progression of Appendiceal Mucinous Neoplasm to Pseudomyxoma Peritonei.” Accepted for publishing in Am Surg October 2020. Podium presentation at Southern California Chapter, American College of Surgeons Annual Scientific Meeting in Santa Barbra, CA, January 2020. Sueda S, Young S, Sung M, Hotta M, O’Connor V, Leung A. “Predictors of Progression of Appendiceal Mucinous Neoplasm to Pseudomyxoma Peritonei.” Accepted for publishing in Am Surg October 2020. Poster presentation at Kaiser Permanente Los Angeles Medical Center Research Day Sueda S. Predictors of Progression of Appendiceal Mucinous Neoplasm to Pseudomyxoma Peritonei. Surgery Research Day, May 2020, Los Angeles, CA Yong H, Sueda S, Leung A. Clinical Impact of Surgery in Patients Undergoing Neoadjuvant Chemotherapy (NAC) on Breast Cancer Recurrence and Survival. Presented at ACS in San Francisco October 2019. Also presented at KP National Symposium in Hawaii Lee, J. Safety and Efficacy of Enhanced Recovery Protocol after Hepatic Resection. Podium presentation at SCCACS, January 2020, Santa Barbara, CA Lee, J. Safety and Efficacy of Enhanced Recovery Protocol after Hepatic Resection. Surgery Research Day, May 2020, Los Angeles, CA Hotta, M. Occult Breast Cancer. Surgery Research Day, May 2020, Los Angeles, CA Ou, R. Acute Exertional Compartment Syndrome. Surgery Research Day, May 2020, Los Angeles, CA Page 3 of 5 Lo HYA, Young S. DiFronzo LA, Laparoscopic Liver Resection: a 7-year Experience of 109 Resections in a Single Institution. Podium presentation presented at the Southern California Chapter American College of Surgeons, January 2020, Santa Barbara, CA, Lo HYA, Young S. DiFronzo LA, Laparoscopic Liver Resection: a 7-year Experience of 109 Resections in a Single Institution. Surgery Research Day, May 2020, Los Angeles, CA Lo HYA, Young S. DiFronzo LA, Laparoscopic Liver Resection: a 7-year Experience of 109 Resections in a Single Institution. LAMC Research week, June 2020, Los Angeles, CA Rettig RL. Cryoablation Associated with Shorter Length of Stay in Pectus Excavatum Repair. Oral Presentation at SCCASC, January 2020, Ventura, CA Rettig RL. Surgery: Evaluation of Opioid-Sparing Multimodal Analgesia Regimen for Postoperative Pain Control during Tonsillectomy with and without Adenoidectomy. Oral Presentation at Kaiser Permanente LAMC Symposium, June 2020, Los Angeles, CA Ashfaq A. Utilization of Mobile Mental Health Services among Syrian Refugees and Other Vulnerable Arab Populations-A Systematic Review. Surgery Research Day, May 2020, Los Angeles, CA Ashfaq A. Utilization of Mobile Mental Health Services among Syrian Refugees and Other Vulnerable Arab Populations-A Systematic Review. LAMC Research Week, June 2020, Los Angeles, CA Motahar B. Intracorporeal versus Extracorporeal Anastomosis in Minimally Invasive Right Hemicolectomy: A Single Institution Case Series Comparison". Podium Presentation at Southern California Chapter of American College of Surgeons, January 2020, Santa Barbara, CA Yong H. Will there be a Role for Surgery in the Future of Breast Cancer Management? Surgery Grand Rounds, May 2020, Los Angeles, CA Cheng M. Surgical Ergonomics. Surgery Grand Rounds, May 2020, Los Angeles, CA Sung M. The Gut Microbiome and Intestinal Anastomosis. Surgery Grand Rounds, June 2020, Los Angeles, CA Mohabbatizadeh B. Perforated Pediatric Appendicitis Severity Scoring. Surgery Research Day, May 2020, Los Angeles, CA Yong H. Clinical Impact of Delaying Surgery in Patients Undergoing Neoadjuvant Chemotherapy (NAC) on Breast Cancer Recurrence and Survival. Surgery Research Day, May 2020, Los Angeles, CA Page 4 of 5 DeCan E. Aggressive Phosphate Repletion Improves Outcomes in Post Hepatectomy Patients. Surgery Research Day, May 2020, Los Angeles, CA Cheng M. Total Occlusion of the Proximal Internal Carotid Artery with Distal Patency Maintained by a Persistent Hypoglossal Artery with Retrograde Flow: A Case Report. Surgery Research Day, May 2020, Los Angeles, CA Desai S. Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias: A Retrospective Study within the Kaiser Permanente Southern California population. Surgery Research Day, May 2020, Los Angeles, CA Huang SY. The Effects of Parathyroidectomy on Nephrolithiasis Recurrence in Patients with Primary Hyperparathyroidism. Surgery Research Day, May 2020, Los Angeles, CA Page 5 of 5 .
Load more

Recommended publications
  • Abdominal and Pelvic Imaging Findings Associated with Sex Hormone Abnormalities
    UCSF UC San Francisco Previously Published Works Title Abdominal and pelvic imaging findings associated with sex hormone abnormalities. Permalink https://escholarship.org/uc/item/7cq623wg Journal Abdominal radiology (New York), 44(3) ISSN 2366-004X Authors Kurzbard-Roach, Nicole Jha, Priyanka Poder, Liina et al. Publication Date 2019-03-01 DOI 10.1007/s00261-018-1844-1 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Abdominal Radiology https://doi.org/10.1007/s00261-018-1844-1 (0123456789().,-volV)(0123456789().,-volV) REVIEW Abdominal and pelvic imaging findings associated with sex hormone abnormalities 1 1 1 2 Nicole Kurzbard-Roach • Priyanka Jha • Liina Poder • Christine Menias Ó Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Hormones are substances that serve as chemical communication between cells. They are unique biological molecules that affect multiple organ systems and play a key role in maintaining homoeostasis. In this role, they are usually produced from a single organ and have defined target organs. However, hormones can affect non-target organs as well. As such, biochemical and hormonal abnormalities can be associated with anatomic changes in multiple target as well as non-target organs. Hormone-related changes may take the form of an organ parenchymal abnormality, benign neoplasm, or even malignancy. Given the multifocal action of hormones, the observed imaging findings may be remote from the site of production, and may actually be multi-organ in nature. Anatomic findings related to hormone level abnormalities and/or laboratory biomarker changes may be identified with imaging. The purpose of this image-rich review is to sensitize radiologists to imaging findings in the abdomen and pelvis that may occur in the context of hormone abnormalities, focusing primarily on sex hormones and their influence on these organs.
    [Show full text]
  • Liver & Pancreas
    276A ANNUAL MEETING ABSTRACTS 1263 Renal Pathology in Hematopoeitic Cell Transplantation Design: We studied 58 consecutive liver allografts from 53 pediatric patients (<18 Recipients yrs) who underwent OLT from 1995-2006. All allograft biopsies were scored for the ML Troxell, M Pilapil, D Miklos, JP Higgins, N Kambham. OHSU, Portland, OR; following features: 1) CLH (mild, moderate, severe), 2) portal AR (mild, moderate, Stanford Univ, Stanford, CA. severe), 3) zone 3 fibrosis (mild=perivenular or severe=bridging), and 4) ductopenia. Background: Hematopoietic cell transplantation (HCT) associated acute and chronic Five explanted livers that were removed during the course of retransplantation for graft renal toxicity can be due to cytotoxic conditioning agents, radiation, infection, failure in this group were also reviewed. immunosuppressive agents, ischemia, and graft versus host disease (GVHD). We have Results: Mean age at OLT was 7 yrs (range 7 wks-18 yrs) with 29 boys and 24 girls. reviewed consecutive renal biopsy specimens in HCT patients from a single center. We reviewed a total of 417 allograft biopsies (mean 7.2 per allograft) obtained 2 days Design: The files of Stanford University Medical Center Department of Pathology were - 11 yrs post-OLT; 200 (48%) of these were protocol biopsies. Forty-six allografts (79%) searched for renal biopsy specimens in patients who received HCT (1995-2005); 11 had >1 yr of histologic follow-up, 29 (50%) had >3 yrs, and 21 (36%) >5 yrs. Overall, cases were identified (post BMT time 0.7 to 14.5 years). The biopsies were processed CLH was observed on at least one occasion in 38 (66%) allografts.
    [Show full text]
  • "Gastrointestinal Tract Pathology"
    IIC,J CALIFORNIA TUMOR TISSUE REGISTRY "GASTROINTESTINAL TRACT PATHOLOGY" Study Cases, Subscription A March 2000 California Tumor Tissue Registry c/o: De1mrtment of Pathology and Human Anatomy Loma Linda Univcr.;ily School ofMcd.icine 11021 Campus Avenue, AH 335 Lomn Linda, California 92350 (909) 558-4788 FAX: (909) 558·0188 E-mail: [email protected] Case oftbe Month: www.llu.edu/Uu/cttr/cotm Target audience: Practicing pathologists and pathology residents. Goal: To acquairu the participam with the hiswlogic featu res of a variety of benign and malignant neoplasms and tumor-l ike conditions. Objectives: n1e participant will be able to recognize morphologic features ofa variety of benign and malignam neoplasms and tWllOr-like conditions and relate those processes to pertinent references in d1e medical literature. Educational methods and media: Review of representative glass slides v.ith associated histories. Feedback on consensus diagnoses lt·om participating pathologists. Listing of selected references from the medical literature. Principal faculty: Weldon K. Bullock, Ml) Donald R. Chase, MD CME Credit: Lorna Li.nda University School of Medicine designates this continuing medical education·activity for up to 2 hours of Category I of the Physician's Recogn ition Award oft he· American Medical Association. CME credit is offered for d1e subscription year only. Accreditation: Loma Linda University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. Contributor: James A. Henry, M.D. Case No. 1 - March 2000 Woodbridge, VA Tissue from: Terminal ileum Accession #28502 Clinical Abstract: This 37-year-old black female presented with several weeks' history of right lower quadrant abdominal pain radiating to the right side of the back and right inguinal area.
    [Show full text]
  • Conversion of Morphology of ICD-O-2 to ICD-O-3
    NATIONAL INSTITUTES OF HEALTH National Cancer Institute to Neoplasms CONVERSION of NEOPLASMS BY TOPOGRAPHY AND MORPHOLOGY from the INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY, SECOND EDITION to INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY, THIRD EDITION Edited by: Constance Percy, April Fritz and Lynn Ries Cancer Statistics Branch, Division of Cancer Control and Population Sciences Surveillance, Epidemiology and End Results Program National Cancer Institute Effective for cases diagnosed on or after January 1, 2001 TABLE OF CONTENTS Introduction .......................................... 1 Morphology Table ..................................... 7 INTRODUCTION The International Classification of Diseases for Oncology, Third Edition1 (ICD-O-3) was published by the World Health Organization (WHO) in 2000 and is to be used for coding neoplasms diagnosed on or after January 1, 2001 in the United States. This is a complete revision of the Second Edition of the International Classification of Diseases for Oncology2 (ICD-O-2), which was used between 1992 and 2000. The topography section is based on the Neoplasm chapter of the current revision of the International Classification of Diseases (ICD), Tenth Revision, just as the ICD-O-2 topography was. There is no change in this Topography section. The morphology section of ICD-O-3 has been updated to include contemporary terminology. For example, the non-Hodgkin lymphoma section is now based on the World Health Organization Classification of Hematopoietic Neoplasms3. In the process of revising the morphology section, a Field Trial version was published and tested in both the United States and Europe. Epidemiologists, statisticians, and oncologists, as well as cancer registrars, are interested in studying trends in both incidence and mortality.
    [Show full text]
  • Neoplasms of the Liver
    Modern Pathology (2007) 20, S49–S60 & 2007 USCAP, Inc All rights reserved 0893-3952/07 $30.00 www.modernpathology.org Neoplasms of the liver Zachary D Goodman Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC, USA Primary neoplasms of the liver are composed of cells that resemble the normal constituent cells of the liver. Hepatocellular carcinoma, in which the tumor cells resemble hepatocytes, is the most frequent primary liver tumor, and is highly associated with chronic viral hepatitis and cirrhosis of any cause. Benign tumors, such as hepatocellular adenoma in a noncirrhotic liver or a large, dysplastic nodule in a cirrhotic liver, must be distinguished from well-differentiated hepatocellular carcinoma. Cholangiocarcinoma, a primary adenocarci- noma that arises from a bile duct, is second in frequency. It is associated with inflammatory disorders and malformations of the ducts, but most cases are of unknown etiology. Cholangiocarcinoma resembles adenocarcinomas arising in other tissues, so a definitive diagnosis relies on the exclusion of an extrahepatic primary and distinction from benign biliary lesions. Modern Pathology (2007) 20, S49–S60. doi:10.1038/modpathol.3800682 Keywords: hepatocellular carcinoma; hepatocellular adenoma; dysplastic nodule; cholangiocarcinoma A basic principle of pathology is that a neoplasm more than 3 to 1 (Figure 1). Among primary liver usually differentiates in the manner of cells that are tumors that come to clinical attention, over three- normally present in the tissue in which the fourths are hepatocellular carcinoma (HCC), while neoplasm arises. Thus, primary neoplasms and the second most common primary malignancy, tumor-like lesions that occur in the liver usually cholangiocarcinoma (CC) accounts for 8% (Figure resemble the major constituent cells of the liver, 2).
    [Show full text]
  • ASC Webinar: Practical Approach to Liver Cytology Indication
    ASC Webinar: Practical Approach to Liver Cytology Barbara A. Centeno, M.D. Director of AP Quality Assurance Director of Cytopathology and Senior member/Moffitt Cancer Center Professor/Departments of Oncologic Sciences Morsani College of Medicine University of South Florida 1 LIVER OUTLINE • Background • Cytology of benign liver and liver nodules • Cytology of Primary Liver Cancers – Hepatocellular carcinoma – Cholangiocarcinoma • Ancillary studies for key differential diagnoses • Metastases 2 Indication: Evaluation of a Mass • Nonneoplastic lesions – hemangioma • Benign liver nodule –FNH – Adenoma • Primary epithelial cancers – HCC –ICC • Less common nonepithelial neoplasms and malignancies • Metastases 3 KEY DIAGNOSTIC ISSUES • Distinction of benign or reactive hepatocytes in nonneoplastic or benign liver nodules from well- differentiated hepatocellular carcinoma • Distinction of poorly differentiated hepatocellular carcinoma from cholangiocarcinoma or metastases • Determination of primary site of origin of metastases • Determination of histogenesis of poorly differentiated malignancie 4 APPROACH TO THE DIAGNOSIS OF LIVER LESIONS • Clinical history – Age and gender • Hepatoblastoma in infants • Adenoma in females – Underlying liver disease • HCV and Cirrhosis as a predisposing risk factor for HCC – Previous history of carcinoma • Radiological imaging – Borders, possible vascular lesion • Cytological findings • Ancillary studies • Correlate all findings 5 Hepatocytes • Monolayered sheets,thin trabeculae, single cells or small, loose groups
    [Show full text]
  • Biopsy Interpretation of Liver Tumors
    Biopsy interpretation of liver tumors Rish K. Pai MD, PhD Professor of Laboratory Medicine & Pathology Mayo Clinic Arizona Florida Society of Pathology Summer 2019 [email protected] ©2017 MFMER | slide-1 Liver mass biopsies: Diagnostic issues • Cirrhotics versus non-cirrhotics • Malignant tumor in the liver • How to approach these biopsies and confirm or exclude HCC • Subtypes of HCC and mixed tumors • Well-differentiated HCC • Recognize and correctly classify benign lesions • Recognize lesional tissue • Hepatocellular adenoma • Focal nodular hyperplasia ©2017 MFMER | slide-2 Liver mass biopsies: Upfront work • Have standard protocols for a biopsy of a liver mass • If multiple cores are taken, separate into different blocks • If a big core, divide and separate into two blocks • Cut unstained slides upfront to avoid wasting tissue • Don’t use up all the tissue: • Reserve tissue for molecular testing ©2017 MFMER | slide-3 Classification of liver tumors: Context! Cirrhotic liver Non-Cirrhotic liver • Hepatocellular carcinoma • < 50 y: • Hepatocellular adenoma • Cholangiocarcinoma • Focal nodular hyperplasia • Mixed • Hepatocellular carcinoma HCC/Cholangiocarcinoma • Other primary tumors • Metastases • Macroregenerative nodule (only on explant) • > 50 y: • Metastases • Dysplastic nodule (only on • Hepatocellular carcinoma explant) • Cholangiocarcinoma • Focal nodular hyperplasia • Other primary tumors ©2017 MFMER | slide-4 A note on Dysplastic nodules • Dysplastic nodule is only diagnosed in the setting of known cirrhosis – very rare to diagnose
    [Show full text]
  • Diagnosis and Management of Focal Liver Lesions
    ACG Clinical Guideline: Diagnosis and Management of Focal Liver Lesions Jorge A. Marrero, MD,1 Joseph Ahn, MD, FACG,2 K. Rajender Reddy, MD, FACG3 1University of Texas at Southwestern, Dallas, Texas, USA; 2Oregon Health and Science University, Portland, Oregon, USA; 3University of Pennsylvania, Philadelphia, Pennsylvania, USA Am J Gastroenterol advance online publication 19 August 2014; doi: 10.1038/ajg.2014.213 Abstract Focal liver lesions (FLL) have been a common reason for consultation faced by gastroenterologists and hepatologists. The increasing and widespread use of imaging studies has led to an increase in detection of incidental FLL. It is important to consider not only malignant liver lesions, but also benign solid and cystic liver lesions such as hemangioma, focal nodular hyperplasia, hepatocellular adenoma, and hepatic cysts, in the differential diagnosis. In this ACG practice guideline, the authors provide an evidence-based approach to the diagnosis and management of FLL. Preamble The writing group was invited by the Practice Parameters Committee and the Board of the Trustees of the American College of Gastroenterology to develop a practice guideline regarding the suggested diagnostic approaches and management of focal liver lesions (FLLs). FLLs are solid or cystic masses or areas of tissue that are identified as an abnormal part of the liver. The term “lesion” rather than “mass” was chosen because “lesion” is a term that has a wider application, including solid and cystic masses. This guideline will be limited to primary liver lesions and the management approach to FLLs rather than focusing on the diagnosis and management of metastatic lesions, hepatocellular carcinoma, or cholangiocarcinoma.
    [Show full text]
  • Fat-Containing Lesions of the Liver : a Pictorial Essay
    Diagnostic and Interventional Imaging (2015) 96, 201—211 ICONOGRAPHIC REVIEW / Gastrointestinal imaging Fat-containing lesions of the liver : A pictorial essay a a a M. Tekath , T. Klotz , P.F. Montoriol , c a a,∗,b J. Joubert-Zakeyh , J.-M. Garcier , D. Da Ines a Department of Radiology and Medical Imaging, Clermont-Ferrand University Hospital, Estaing University Hospital, 1, place Luci-Aubrac, 63003 Clermont-Ferrand cedex 1, France b Clermont University, University of Auvergne, ISIT, CNRS, UMR6284, BP 10448, 63000 Clermont-Ferrand, France c Anatomical and Cytological Pathology, Clermont-Ferrand University Hospital, Estaing University Hospital, Estaing University Hospital, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France KEYWORDS Abstract The presence of fat within a hepatic lesion is unusual and can help to direct the Liver tumor; radiologist’s diagnosis. The aim of this iconographic review is to specify the various hepatic Hepatic steatosis; lesions that may contain fat and their appearance particularly on MRI. A histological correlation Magnetic resonance is also suggested for the most commonly found tumors. The identification of fat within a hepatic imaging tumor, along with other radiological signs and reflection on the clinical and epidemiological context, can lead to a diagnosis being reached or suggested, with confirmation if necessary, by a pathological examination. © 2013 Éditions franc¸aises de radiologie. Published by Elsevier Masson SAS. All rights reserved. The presence of fat in a liver lesion is not a standard finding and it can help to guide the radiologist towards a diagnosis. Fat may be macroscopic or microscopic. MRI is the modality of choice for detecting a fatty component in a hepatic tumor: fat-saturation sequence detects extracellular fat while chemical shift imaging identifies microscopic or intracellular lipids [1].
    [Show full text]
  • Pathological Aspects of Hepatocellular Tumors 77 4 Pathological Aspects of Hepatocellular Tumors
    Pathological Aspects of Hepatocellular Tumors 77 4 Pathological Aspects of Hepatocellular Tumors Hale Kirimlioglu, MD, Anthony J. Demetris, MD, and Michael A. Nalesnik, MD CONTENTS HEPATOCELLULAR ADENOMA HEPATOCELLULAR CARCINOMA FIBROLAMELLAR HCC CLEAR CELL HCC SCLEROSING HCC COMBINED HCC AND CHOLANGIOCELLULAR CARCINOMA SARCOMATOID HCC HEPATOBLASTOMA REFERENCES 1. HEPATOCELLULAR ADENOMA Hepatocellular adenoma (HA) is an uncommon and benign tumor of the liver, seen most often in young women of childbearing age with a history of oral contraceptive use (Table 1) (1). The longer the duration of intake of oral contra- ceptives, the higher the risk of developing hepatic adenoma (2). Anabolic steroid use also is associated with HA, and an example of this lesion arising in conjunc- tion with growth hormone therapy for Turner’s syndrome has been reported (3). An association of liver cell adenoma and various genetic metabolic disorders (such as glycogen storage diseases types I, III, or IV, galactosemia, tyrosinemia, and, rarely, diabetes mellitus or familial adenomatous polyposis) also has been reported (4–9). From: Current Clinical Oncology: Hepatocellular Cancer: Diagnosis and Treatment Edited by: B. I. Carr © Humana Press Inc., Totowa, NJ 77 78 Kirimlioglu et al. Table 1 Neoplastic Hepatocellular Lesions: Selected Features Clinical features Pathological features HA Usually single, rarely Clonal growth of normal multiple; associated appearing hepatocytes with birth control pills; with arterial vasculature may bleed and otherwise bland trabecular
    [Show full text]
  • "Gastrointestinal Pathology"
    ' -.. CALIFORNIA TUMOR TISSUE REGISTRY "GASTROINTESTINAL PATHOLOGY" Study Cases, Subscription A November 2007 California Tumor Tissue Registry c/o: Department of Pathology and Hum110 Anatomy Lorna Linda University School of Medicine 11021 Campus A'•eoue, AR 335 Lorna Linda, California 92350 (909) 558-4788 FAX: (909) 558-0188 E-mail: [email protected] Web page: www.c!tr.org Web site & Case of the Month: www.cttr.org Target audience: Practicing pathologists and pathology residents. Goal: . To acquaint the panicipant with the histologic features ofa variety of benign and malignant neoplasms and tumor-like conditions. Objectives: The. panicipant will be uble to recognize morphologic features of a variety of benign and malignant neoplasms and rumor-like conditions and relate those processes to pertinent references in the medical literature. Educational methods and media: Review ofrepresentative glass slides with associated histories. Feedback on consensus diagnoses from participating pathologists. Listing of selected references from the medical literature. Principal faculty: Weldon K. Bullock, MD Donald R. Chase, MD CME Credit: Lorna Linda University School of Medicine designates this continuing medical education activity for a maximum of2 hours of Category I ofthe Physician's Recognition Award ofthe American Medical Association. CME credit is offered for the subscription year only. Accreditation: Lorna Linda University School of Medicine is accredited by the Accreditation Counci l for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. 2 Study Cases, November 2007, Subscription A Contributor: LLUMC Pathology Group (mp) Case No. 1 - November 2007 A Lorna Linda, CA Tissue from: Small bowel Accession #30652 Clinical Abstract: A 74 year old woman had a past history of endometrioid adenocarcinoma of the vagina.
    [Show full text]
  • Hepatocellular Adenoma
    Liver Specialty Evening Conference Matthew M. Yeh, MD, PhD Professor of Pathology Adjunct Professor of Medicine University of Washington, Seattle Case History • A 65 year-old man presents with abdominal pain and abnormal liver tests. • Images of the abdomen reveals a liver mass. • History of non-invasive low-grade urothelial carcinoma 2 months ago, s/p TURP. • No underlying liver diseases or cirrhosis. • AFP: Normal. MR Images in Arterial Phase Non-cirrhotic liver with segment 8/4 lesion. Arterial phase hyperenhancment. Courtesy of Dr. Neeraj Lalwani, UWMC, Seattle MR Images in Venous Phase Non-cirrhotic liver with segment 8/4 lesion. Subtle washout on venous phase. Courtesy of Dr. Neeraj Lalwani, UWMC, Seattle MR Images in Delayed Phase Non-cirrhotic liver with segment 8/4 lesion. Delayed phase also shows subtle washout on venous phase. Courtesy of Dr. Neeraj Lalwani, UWMC, Seattle MR Coronal Image in the Delayed Phase Non-cirrhotic liver, lesion within segment 8/4 associated with PV thrombosis. Suspicion of liver primary vs. metastasis Courtesy of Dr. Neeraj Lalwani, UWMC, Seattle Case • A CT-guided liver biopsy was performed. Differential Diagnosis • Benign liver lesions – Hepatocellular – Biliary – Miscellaneous • Malignant liver lesions – Primary • Hepatocellular • Biliary • Other – Metastatic Differential Diagnosis • Benign liver lesions – Hepatocellular – Biliary – Miscellaneous • Malignant liver lesions – Primary • Hepatocellular • Biliary • Other – Metastatic 6th most common cancer Hepatocellular Carcinoma Risk Factors Traditional Recently Recognized • HBV • HCV • Metabolic • Cirrhosis syndrome and • Alcohol obesity • Aflatoxin • Hemochromatosis • Alpha-1-antitrypsin deficiency • Hepatocellular adenoma Malignant Liver Neoplasms in Non-Cirrhotic Liver Modified from Dr. Zachary Goodman, with permission Malignant Liver Neoplasms in Cirrhosis Modified from Dr.
    [Show full text]